The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status

This publication has 18 references indexed in Scilit:

• Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Thrombosis and hormone replacement therapy in postmenopausal women
  American Journal of Obstetrics and Gynecology, 1993
• Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women
  New England Journal of Medicine, 1993
• Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy
  British Journal of Haematology, 1993
• Menopause, hormone replacement therapy and cardiovascular disease: A review of haemostaseological findings
  Fibrinolysis, 1992
• Hemostatic factors according to menopausal status and use of hormone replacement therapy
  Annals of Epidemiology, 1992
• Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein(a)
  Thrombosis Research, 1992
• Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in posimenopausal women
  Thrombosis Research, 1991
• Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
  Heart, 1988
• Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
  Circulation, 1986